
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Jin Li, Diane J. Burgess
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2110-2124
Open Access | Times Cited: 95
Jin Li, Diane J. Burgess
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2110-2124
Open Access | Times Cited: 95
Showing 1-25 of 95 citing articles:
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 359
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 359
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 268
Shaojun Peng, Fengfeng Xiao, Meiwan Chen, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 268
Preparation and application of pH-responsive drug delivery systems
Haitao Ding, Ping Tan, Shiqin Fu, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 206-238
Closed Access | Times Cited: 231
Haitao Ding, Ping Tan, Shiqin Fu, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 206-238
Closed Access | Times Cited: 231
Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 171
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 171
Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer
Chuan Hu, Xueqin He, Yuxiu Chen, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 11
Closed Access | Times Cited: 122
Chuan Hu, Xueqin He, Yuxiu Chen, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 11
Closed Access | Times Cited: 122
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 121
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 121
Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
Qi Qiao, Xiong Liu, Ting Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3060-3091
Open Access | Times Cited: 120
Qi Qiao, Xiong Liu, Ting Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3060-3091
Open Access | Times Cited: 120
Insights on functionalized carbon nanotubes for cancer theranostics
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 113
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 113
mRNA cancer vaccines: Advances, trends and challenges
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 91
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 91
Cell-based drug delivery systems and their in vivo fate
Liuxin Yang, Yang Yang, Yang Chen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114394-114394
Closed Access | Times Cited: 81
Liuxin Yang, Yang Yang, Yang Chen, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114394-114394
Closed Access | Times Cited: 81
The pursuit of polymethine fluorophores with NIR-II emission and high brightness forin vivoapplications
Xuan Zhao, Fan Zhang, Zuhai Lei
Chemical Science (2022) Vol. 13, Iss. 38, pp. 11280-11293
Open Access | Times Cited: 74
Xuan Zhao, Fan Zhang, Zuhai Lei
Chemical Science (2022) Vol. 13, Iss. 38, pp. 11280-11293
Open Access | Times Cited: 74
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2023) Vol. 574, pp. 216397-216397
Open Access | Times Cited: 59
Mengdan Xu, Shenglong Li
Cancer Letters (2023) Vol. 574, pp. 216397-216397
Open Access | Times Cited: 59
Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges
Iman Salahshoori, Mahdi Golriz, Marcos A.L. Nobre, et al.
Journal of Molecular Liquids (2023) Vol. 395, pp. 123888-123888
Open Access | Times Cited: 48
Iman Salahshoori, Mahdi Golriz, Marcos A.L. Nobre, et al.
Journal of Molecular Liquids (2023) Vol. 395, pp. 123888-123888
Open Access | Times Cited: 48
The past, present, and future of breast cancer models for nanomedicine development
Paz Boix-Montesinos, Paula M. Soriano‐Teruel, Ana Armiñán, et al.
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 306-330
Open Access | Times Cited: 96
Paz Boix-Montesinos, Paula M. Soriano‐Teruel, Ana Armiñán, et al.
Advanced Drug Delivery Reviews (2021) Vol. 173, pp. 306-330
Open Access | Times Cited: 96
Delivery strategies of amphotericin B for invasive fungal infections
Xiaochun Wang, Imran Shair Mohammad, Lifang Fan, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2585-2604
Open Access | Times Cited: 92
Xiaochun Wang, Imran Shair Mohammad, Lifang Fan, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2585-2604
Open Access | Times Cited: 92
Furin-instructed aggregated gold nanoparticles for re-educating tumor associated macrophages and overcoming breast cancer chemoresistance
Rou Xie, Shaobo Ruan, Jiaqi Liu, et al.
Biomaterials (2021) Vol. 275, pp. 120891-120891
Closed Access | Times Cited: 70
Rou Xie, Shaobo Ruan, Jiaqi Liu, et al.
Biomaterials (2021) Vol. 275, pp. 120891-120891
Closed Access | Times Cited: 70
Charge-reversal nanomedicines as a smart bullet for deep tumor penetration
Zimu Li, Yiwen Gao, Wen Li, et al.
Smart Materials in Medicine (2022) Vol. 3, pp. 243-253
Open Access | Times Cited: 65
Zimu Li, Yiwen Gao, Wen Li, et al.
Smart Materials in Medicine (2022) Vol. 3, pp. 243-253
Open Access | Times Cited: 65
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
Yongchao Wang, Jinjin Wang, Dandan Zhu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 4, pp. 886-902
Open Access | Times Cited: 64
Yongchao Wang, Jinjin Wang, Dandan Zhu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 4, pp. 886-902
Open Access | Times Cited: 64
Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy
Hao Ren, Jiahui Yong, Qingqing Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3244-3261
Open Access | Times Cited: 58
Hao Ren, Jiahui Yong, Qingqing Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3244-3261
Open Access | Times Cited: 58
Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages
Wenqi Yu, Chuan Hu, Huile Gao
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113909-113909
Closed Access | Times Cited: 54
Wenqi Yu, Chuan Hu, Huile Gao
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113909-113909
Closed Access | Times Cited: 54
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 27
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 27
Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome
Yitianhe Xu, Leyao Lv, Qian Wang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113869-113869
Closed Access | Times Cited: 8
Yitianhe Xu, Leyao Lv, Qian Wang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113869-113869
Closed Access | Times Cited: 8
Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy
Lianyi Yang, Yazhen Wang, Yujun Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 354-366
Closed Access | Times Cited: 8
Lianyi Yang, Yazhen Wang, Yujun Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 354-366
Closed Access | Times Cited: 8
Targeted Delivery of Geraniol via Hyaluronic Acid-Conjugation Enhances Its Anti-Tumor Activity Against Prostate Cancer
Yu Han, Ning Na, Fujin He, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 155-169
Open Access | Times Cited: 7
Yu Han, Ning Na, Fujin He, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 155-169
Open Access | Times Cited: 7
Camouflaged Hybrid Cancer Cell‐Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple‐Negative Breast Cancer to Doxorubicin
Yi Liu, Uday Kumar Sukumar, Masamitsu Kanada, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 41
Open Access | Times Cited: 44
Yi Liu, Uday Kumar Sukumar, Masamitsu Kanada, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 41
Open Access | Times Cited: 44